Linda Liang

Linda Liang began their career as a scientist at Phylogix in 2002. Linda then spent two years at Organon before joining Merck Research Laboratories in 2007 as a principal scientist. In 2015, they left Merck to join Bristol-Myers Squibb as an associate director/hybridoma leader. Linda left Bristol-Myers Squibb in 2019 to join Pionyr Immunotherapeutics as VP of protein sciences.

Linda Liang completed their BA in Biology at The Johns Hopkins University and their PhD in Immunology at University of California, Berkeley.

They work with Lynnae Jackson - Senior Director, Clinical Operations, Kristen Pierce - VP, Translational Medicine, and Isabel Luther - Senior Director, Clinical Operations. Linda Liang reports to Leonard Reyno, EVP & Chief Medical Officer.